Alzheimer's/Park/Hunt/ALS Rx- Dersh Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Levodopa

Mechanism?

Adverse effects?

Use?

Caution

A

MOA:

  • Dopamine Precursor (Converted to Dopamine in Brain)
  • Increases [DA] concentration in presynaptic terminals
  • Given with Carbidopa (Inhibits AAAD) to prevent peripheral breakdown into DA (which can not cross BBB)

AE: (A UNH DOC)

  • Arrhythmia
  • Upset Stomach Vomiting
  • Nausea (Stimulates CTZ)
  • Hallucinations
  • Dyskinesias (Choreiform, dystonia)
  • Orthostatic Hypotension
  • Confusion and Psychosis

AE:
-Formation of Hydrogen Peroxide (H2O2) which is neurotoxic.

Rx:

  • Mild to Moderate PD
  • Reduces Tremors, rigidity, bradykinesia

Note: When discontinuing the drug, slowly taper in order to prevent neuroleptic malignant syndrome.

Note: caution and tape with MAO-I to avoid hypertensive crisis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bromocriptine

Mechanism?

AE?

Use?

A

MOA:

  • Ergot Derivative
  • Dopa Agonist (D3, D2, & Partial D1)

AE: “PROV” it “Bro”

  • Pulmonary Fibrosis
  • Retroperitoneal Fibrosis
  • Orthostatic Hypotension (Partial D1 agonism)
  • Vasospasm (Avoid use in Lupus and Reynauds Pts)

Rx:

  • Mild to Moderate PD
  • To block Increased GH and Prolactin in endocrine patients. Recall Dopamine is inhibitory in this function.

Note:

  • Must take Drug Holidays to prevent Pulmonary Fibrosis
  • Don’t forget Ergot Poisoning Triad
  • “An OLE HAG”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pramipexole

Mechanism?

AE?

Use?

A

MOA:

  • D3 and D2 Agonist
  • D3 > D2
  • Not an Ergot (so no D1 agonism)
  • Longer Duration than Bromocriptine***

AE:
-Similar to Bromocriptine except: no Orthostatic Hypotension and no Fibrosis.

Rx:
-Mild to Moderate PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the advantages of Dopamine Agonists over Levodopa?

A

Mnemonic: NSNL

  • No H2O2 production
  • Selective for DA receptor subtypes
  • No enzyme requirement by the intact neuron to convert it.
  • Longer duration of action
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Ergot? And What is the Ergot Triad?

A
  • Ergot is a fungus that grows on grain (especially Rye).
  • Can be Poisonous (especially to an old “HAG”)

Triad of Ergot Poisoning: HAG

  • Hallucinations (5HT2 agonism, Lysergic acid)
  • Abortion (Direct stimulation of Uterine tissue)
  • Gangrene (alpha adrenergic agonist –> Vasoconstriction, –> Necrosis)

Note: Bromocriptine derived from Ergot family.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ropinirole

Mechanism?

AE?

A

MOA:

  • D3 and D2 Agonist
  • D3 > D2
  • Not an Ergot (so no D1 agonism)
  • Longer Duration than Bromocriptine***
  • Ropinirol available in sustained release preparation

AE:
-Similar to Bromocriptine except: no Orthostatic Hypotension and no Fibrosis.

Rx:
-Mild to Moderate PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Selegiline

Mechanism?

Adverse effect?

Use?

A

MAO: “Selective Selegiline”

  • Selective Inhibitor of MAO-B (Only in CNS)
  • Decreases DA metabolism
  • Decreases neuronal production of H2O2.
  • Active Metabolites (amphetamine and methamphetamine)
  • Available in Transdermal and ODT form to avoid 1st pass metabolism and production of metabolites.

AE: (IME)

  • Insomnia (active metabolites)
  • May potentiate adverse motor effects of levodopa in progressed PD.
  • Euphoria (active metabolites)

Rx:

  • First line therapy for Early PD
  • Delays the use for Levodopa (Recall that tolerance to levodopa builds quickly)

Note: Does not inhibit MAO-A found in the gut, therefore patients do not need to modify diet to avoid tyramine induced hypertensive crisis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rasagiline

Mechanism?

AE?

A

MOA:

  • Selective Inhibitor of MAO-B (10x more Potent than Selegiline)
  • Decreases DA metabolism
  • Decreases neuronal production of H2O2.
  • Metabolized into inactive compounds

AE:

  • Less toxic than Selegiline
  • Hypertensive Crisis if co-administered with CYP1A2 inhibitors (Ciprofloxacin, fluvoxamine).

Note: At high concentrations it loses selectivity for MAO-B.

Rx:

  • Used as first line PD treatment.
  • Delays use of Levodopa.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Amantadine

Mechanism?

AE?

A

MOA:

  • NMDA Antagonist
  • Muscarinic Receptor Antagonist (reduces Tremor)

AE:

  • Insomnia
  • Concentration difficulty
  • Enxiety (anxiety)
  • Seizure exacerbation

Rx:

  • Used to treat Early PD (Can also be used in conjunction with other drugs in advanced PD therapy).
  • Initially used to prevent Influenza A in high risk populations.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tolcapone

Mechanism?

AE?

Use?

A

MOA:

  • COMT Inhibitor
  • Inhibit catechol-O-methyltransferase (COMT), therefore inhibits levodopa metabolism in periphery.
  • Increases circulating half life of Levodopa.
  • Long acting, take 2-3x per day

AE: Al Capone shoots you in the liver.

  • Hepatic Necrosis (Pts must have Liver monitored regularly)
  • Caution in raising Levodopa concentrations too much.

Rx:
-Used with Levodopa to treat PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Entacapone

Mechanism?

AE?

Use?

A

MOA:

  • COMT Inhibitor
  • Inhibits COMT, therefore reduces Levodopa metabolism in the periphery.
  • Increases circulating half life of Levodopa.
  • Short acting, take 4-6x per day

AE:
-Caution for Increasing Levodopa concentrations too much.

Rx:
-Used with Levodopa to treat PD

Note: COMT Inhibitors are less toxic than DA agonists and Muscarinic Antagonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Levodopa Refractoriness

A

Manifests as decreased duration of effect after each dose. May lead to On/Off Phenomenon.

On/Off Phenomenon:

  • Alternating periods of Severe Choreiform movement and near-total rigidity
  • Short periods of functional motor ability in between.

Note: These are end-stage symptoms. More frequent Levodopa dosing and supplement with other PD drugs can help symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Inhibitors of Acetylcholinesterase

Mechanism?

AE?

A

Mnemonic: DR. GT (These drugs make the mind faster, GT)

MOA:

  • Potentiates Cholinergic transmission by inhibiting Acetylcholinesterase.
  • Results in better memory and cognitive function

AE: DNV BIN

  • Cholinergic Excess Side effects:
  • Diarrhea
  • Nausea
  • Vomiting
  • Bradycardia
  • Insomnia
  • Nightmares

AChE Inhibitor Drugs: DRGT

  • Donepezil
  • Rivastigmine
  • Galantamine
  • Tacrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Donepezil

Mechanism?

AE?

Use?

A

MOA:

  • Acetylcholinesterase Inhibitor
  • Available as ODT to bypass the GI effects.

AE: DNV BIN

  • Cholinergic Excess (DNV)
  • Bradycardia
  • Insomnia
  • Nightmares

Rx:
-Mild to Moderate Alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rivastigmine

Mechanism?

AE?

Use?

A

MOA:

  • Acetylcholinesterase Inhibitor
  • Available as Transdermal patch

AE:
-Cholinergic Excess (DNV)

Rx:
-Mild to Moderate Alzheimer’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Galantamine

Mechanism?

AE?

Use?

A

MOA:
-Acetylcholinesterase Inhibitor

AE:
-Cholinergic Excess (DNV)

Rx:
-Mild to Moderate Alzheimer’s

17
Q

Tacrine

Mechanism?

AE?

Use?

A

MOA:
-Acetylcholinesterase Inhibitor

AE:

  • Hepatotoxicity is VERY common
  • Cholinergic Excess (DNV)
  • BIN

Rx:

  • This drug is no longer used
  • Alzheimer’s (Former use)

Note: First AChE Inhibitor used for Alzheimer’s Rx.

18
Q

Aspirin

What is it’s effect on neurogeneretive disease?

A

MOA:
-COX Inhibition

AE:

  • Bleeding
  • Ulcers

Rx:

  • May prevent and/or delay the progression of Alzheimer’s.
  • May cause regression of plaques
19
Q

Memantine

Mechanism?

AE?

Use?

A

MOA:

  • NDMA Antagonist
  • Reduces the rate of clinical deterioration in Alzheimer’s patients
  • Used in combination with ACHe Inhibitors

AE:

  • Headache
  • Dizziness

Rx:

  • Moderate Alzheimer’s Disease
  • Dementia

Note: MEMantine = MEMory

20
Q

Tetrabenazine

Mechanism?

AE?

Use?

A

MOA:

  • Deplete nerve terminals of neurotransmitters (especially Dopamine)
  • Reduces Choreiform movements by this mechanism

AE:

  • Paranoia
  • Depression

Rx:
-Huntington’s Disease Chorea

Note: Tetra decreases the tantra

21
Q

Riluzole

Mechanism?

AE?

Use?

A

MOA:

  • Prevents Glutamate release
  • Blocks NMDA receptors

Rx:

  • ALS
  • Only indication is to prolong survival.

Note: Prolongs time between ALS diagnosis and need for Tracheostomy by 2 months.

22
Q

Tizanidine

Mechanism?

AE?

Use?

A

MOA:

  • Centrally acting muscle relaxant
  • a2-adrenoreceptor agonist
  • Resulting in presynaptic inhibition of motor neurons

AE:
-None noted

Rx:

  • ALS
  • Reduces spasticity, muscle spasms, and pain
23
Q

Baclofen

Mechanism

AE?

Use?

A

MOA:

  • Centrally acting muscle relaxant
  • GABA(b) receptor agonist (located in spinal cord)

AE:
-None known

Rx:

  • ALS
  • Reduces spasticity, muscle spasms, and pain.